# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
These four companies appear to be a good deal based on future earnings expectations and trading at a low price/earnings (P/E) r...
Barclays analyst Andrew Mok maintains Centene (NYSE:CNC) with a Overweight and raises the price target from $101 to $104.
Wellcare, the Medicare business of Centene Corporation (NYSE:CNC), and Wellvana, a value-based care physician enablement compan...
Deutsche Bank analyst George Hill maintains Centene (NYSE:CNC) with a Hold and raises the price target from $81 to $82.
Oppenheimer analyst Michael Wiederhorn maintains Centene (NYSE:CNC) with a Outperform and maintains $110 price target.
Centene outperforms expectations with $40.41 billion in Q1 sales, driven by robust growth in premium revenues and steady member...